Pharmabiz15h
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Pharmabiz17h
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...
Pharmabiz14h
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz18h
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...
Pharmabiz15h
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...
Pharmabiz12h
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz15h
Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India
Our Bureau, Mumbai Friday, January 10, 2025, 14:45 Hrs [IST] ...
Pharmabiz18h
STADA has retained Andreas Fibig as independent chairman of its future board of directors
In the event of an IPO, the board of directors will become the top leadership body of the German healthcare company and ...
Pharmabiz16h
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...
Pharmabiz14h
Medi Assist’s 2024 findings shed light on rising costs, incidence and demography wise hospitalisation patterns
Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...
Pharmabiz15h
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...
Pharmabiz14h
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost, demands AiMeD
Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] ...